ES2692434T3 - Aparato de tratamiento térmico para tratar la disfunción de la glándula de Meibomio - Google Patents
Aparato de tratamiento térmico para tratar la disfunción de la glándula de Meibomio Download PDFInfo
- Publication number
- ES2692434T3 ES2692434T3 ES08727830.5T ES08727830T ES2692434T3 ES 2692434 T3 ES2692434 T3 ES 2692434T3 ES 08727830 T ES08727830 T ES 08727830T ES 2692434 T3 ES2692434 T3 ES 2692434T3
- Authority
- ES
- Spain
- Prior art keywords
- eyelid
- heat
- ocular
- force
- receptacle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004175 meibomian gland Anatomy 0.000 title claims abstract description 303
- 238000010438 heat treatment Methods 0.000 title claims abstract description 153
- 230000004064 dysfunction Effects 0.000 title claims abstract description 16
- 210000000744 eyelid Anatomy 0.000 claims abstract description 655
- 210000001519 tissue Anatomy 0.000 claims abstract description 30
- 210000003786 sclera Anatomy 0.000 claims abstract description 6
- 210000004279 orbit Anatomy 0.000 claims abstract 4
- 230000001105 regulatory effect Effects 0.000 claims description 58
- 239000012530 fluid Substances 0.000 claims description 53
- 230000007246 mechanism Effects 0.000 claims description 41
- 239000000463 material Substances 0.000 claims description 22
- 238000009413 insulation Methods 0.000 claims description 7
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 6
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 6
- 239000000560 biocompatible material Substances 0.000 claims description 5
- 229920003023 plastic Polymers 0.000 claims description 5
- 239000004033 plastic Substances 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 239000003822 epoxy resin Substances 0.000 claims description 3
- 229920000647 polyepoxide Polymers 0.000 claims description 3
- 229920004142 LEXAN™ Polymers 0.000 claims description 2
- 239000004418 Lexan Substances 0.000 claims description 2
- 238000009429 electrical wiring Methods 0.000 claims 2
- 230000005611 electricity Effects 0.000 claims 2
- 238000005485 electric heating Methods 0.000 claims 1
- 238000011282 treatment Methods 0.000 description 106
- 210000004907 gland Anatomy 0.000 description 67
- 239000010410 layer Substances 0.000 description 52
- 210000001508 eye Anatomy 0.000 description 48
- 238000002560 therapeutic procedure Methods 0.000 description 47
- 150000002632 lipids Chemical class 0.000 description 44
- 238000012546 transfer Methods 0.000 description 41
- 230000000007 visual effect Effects 0.000 description 40
- 238000000034 method Methods 0.000 description 32
- 230000001225 therapeutic effect Effects 0.000 description 31
- 238000010586 diagram Methods 0.000 description 29
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 28
- 206010013774 Dry eye Diseases 0.000 description 26
- 210000002374 sebum Anatomy 0.000 description 25
- 239000000725 suspension Substances 0.000 description 25
- 230000006378 damage Effects 0.000 description 24
- 239000002831 pharmacologic agent Substances 0.000 description 23
- 230000028327 secretion Effects 0.000 description 23
- 230000017531 blood circulation Effects 0.000 description 22
- 210000005252 bulbus oculi Anatomy 0.000 description 22
- 230000004927 fusion Effects 0.000 description 21
- 238000000605 extraction Methods 0.000 description 18
- 230000002829 reductive effect Effects 0.000 description 15
- 206010061218 Inflammation Diseases 0.000 description 14
- 230000004054 inflammatory process Effects 0.000 description 14
- 230000033001 locomotion Effects 0.000 description 14
- 150000001875 compounds Chemical class 0.000 description 13
- 238000001704 evaporation Methods 0.000 description 12
- 230000008020 evaporation Effects 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 239000003098 androgen Substances 0.000 description 11
- 229940030486 androgens Drugs 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 10
- 230000006835 compression Effects 0.000 description 10
- 238000007906 compression Methods 0.000 description 10
- 210000000795 conjunctiva Anatomy 0.000 description 10
- 210000003811 finger Anatomy 0.000 description 10
- 206010065062 Meibomian gland dysfunction Diseases 0.000 description 9
- 239000006196 drop Substances 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 238000012423 maintenance Methods 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 230000009471 action Effects 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 210000004379 membrane Anatomy 0.000 description 8
- 239000012528 membrane Substances 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 7
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 7
- 239000004098 Tetracycline Substances 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 235000019364 tetracycline Nutrition 0.000 description 6
- 150000003522 tetracyclines Chemical class 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 208000001860 Eye Infections Diseases 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000033228 biological regulation Effects 0.000 description 5
- 230000036760 body temperature Effects 0.000 description 5
- 208000011323 eye infectious disease Diseases 0.000 description 5
- 230000000762 glandular Effects 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 230000036407 pain Effects 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 229960002180 tetracycline Drugs 0.000 description 5
- 229930101283 tetracycline Natural products 0.000 description 5
- 206010002091 Anaesthesia Diseases 0.000 description 4
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 230000037005 anaesthesia Effects 0.000 description 4
- 230000004397 blinking Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000012768 molten material Substances 0.000 description 4
- 230000000580 secretagogue effect Effects 0.000 description 4
- 206010006797 Burns first degree Diseases 0.000 description 3
- 206010006802 Burns second degree Diseases 0.000 description 3
- 206010006803 Burns third degree Diseases 0.000 description 3
- 206010027137 Meibomianitis Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 210000004087 cornea Anatomy 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 238000009434 installation Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000005461 lubrication Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000000414 obstructive effect Effects 0.000 description 3
- 230000037325 pain tolerance Effects 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 206010010804 Contact lens intolerance Diseases 0.000 description 2
- 229930105110 Cyclosporin A Natural products 0.000 description 2
- 108010036949 Cyclosporine Proteins 0.000 description 2
- 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000012868 Overgrowth Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229960001265 ciclosporin Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000001010 compromised effect Effects 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000003889 eye drop Substances 0.000 description 2
- 229940012356 eye drops Drugs 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- -1 fatty acid compounds Chemical class 0.000 description 2
- 229940013317 fish oils Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000005128 keratinized epithelium Anatomy 0.000 description 2
- 210000004561 lacrimal apparatus Anatomy 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 229940124624 oral corticosteroid Drugs 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000011253 protective coating Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 229940053174 restasis Drugs 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 238000000015 thermotherapy Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 229920000106 Liquid crystal polymer Polymers 0.000 description 1
- 239000004977 Liquid-crystal polymers (LCPs) Substances 0.000 description 1
- 102000015728 Mucins Human genes 0.000 description 1
- 108010063954 Mucins Proteins 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 229920005830 Polyurethane Foam Polymers 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 230000008275 binding mechanism Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000013481 data capture Methods 0.000 description 1
- 238000013479 data entry Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 230000008713 feedback mechanism Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229940051875 mucins Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 239000011496 polyurethane foam Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 229940080150 systane Drugs 0.000 description 1
- 230000004489 tear production Effects 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 229940125379 topical corticosteroid Drugs 0.000 description 1
- 238000011277 treatment modality Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/02—Compresses or poultices for effecting heating or cooling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
- A61F2007/0002—Head or parts thereof
- A61F2007/0004—Eyes or part of the face surrounding the eyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0086—Heating or cooling appliances for medical or therapeutic treatment of the human body with a thermostat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/007—Heating or cooling appliances for medical or therapeutic treatment of the human body characterised by electric heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00718—Restoration of lid function
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Thermal Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Massaging Devices (AREA)
- Percussion Or Vibration Massage (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88085007P | 2007-01-17 | 2007-01-17 | |
| US880850P | 2007-01-17 | ||
| PCT/US2008/051309 WO2008089327A1 (en) | 2007-01-17 | 2008-01-17 | Methods, systems, and apparatuses for heat treatment for treating meibomian gland dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2692434T3 true ES2692434T3 (es) | 2018-12-03 |
Family
ID=39636379
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES08727830.5T Active ES2692434T3 (es) | 2007-01-17 | 2008-01-17 | Aparato de tratamiento térmico para tratar la disfunción de la glándula de Meibomio |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP3434313A1 (cg-RX-API-DMAC10.html) |
| JP (2) | JP5406728B2 (cg-RX-API-DMAC10.html) |
| CN (3) | CN103181837B (cg-RX-API-DMAC10.html) |
| BR (1) | BRPI0806635A2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2692434T3 (cg-RX-API-DMAC10.html) |
| IL (1) | IL199920A0 (cg-RX-API-DMAC10.html) |
| SG (2) | SG177990A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2008089327A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070060988A1 (en) | 2005-07-18 | 2007-03-15 | Grenon Stephen M | Melting meibomian gland obstructions |
| US8083787B2 (en) | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
| WO2013003594A2 (en) | 2011-06-28 | 2013-01-03 | Tearscience, Inc. | Methods and systems for treating meibomian gland dysfunction using radio-frequency energy |
| US7981145B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience Inc. | Treatment of meibomian glands |
| US7981095B2 (en) | 2005-07-18 | 2011-07-19 | Tearscience, Inc. | Methods for treating meibomian gland dysfunction employing fluid jet |
| US8950405B2 (en) | 2006-05-15 | 2015-02-10 | Tearscience, Inc. | Treatment of obstructive disorders of the eye or eyelid |
| US20080114423A1 (en) | 2006-05-15 | 2008-05-15 | Grenon Stephen M | Apparatus for inner eyelid treatment of meibomian gland dysfunction |
| US20090043365A1 (en) | 2005-07-18 | 2009-02-12 | Kolis Scientific, Inc. | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma |
| US8137390B2 (en) | 2006-05-15 | 2012-03-20 | Tearscience, Inc. | System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction |
| US8128673B2 (en) | 2006-05-15 | 2012-03-06 | Tearscience, Inc. | System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction |
| US9314369B2 (en) | 2006-05-15 | 2016-04-19 | Tearscience, Inc. | System for inner eyelid treatment of meibomian gland dysfunction |
| US8128674B2 (en) | 2006-05-15 | 2012-03-06 | Tearscience, Inc. | System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction |
| CN103251375B (zh) | 2009-04-01 | 2016-09-28 | 眼泪科学公司 | 用于成像和测量泪液膜层一个或多个厚度的仪器 |
| US9642520B2 (en) | 2009-04-01 | 2017-05-09 | Tearscience, Inc. | Background reduction apparatuses and methods of ocular surface interferometry (OSI) employing polarization for imaging, processing, and/or displaying an ocular tear film |
| US9888839B2 (en) | 2009-04-01 | 2018-02-13 | Tearscience, Inc. | Methods and apparatuses for determining contact lens intolerance in contact lens wearer patients based on dry eye tear film characteristic analysis and dry eye symptoms |
| US9510972B2 (en) * | 2012-01-04 | 2016-12-06 | Sight Sciences, Inc. | Dry eye treatment systems |
| WO2013114127A1 (en) * | 2012-02-03 | 2013-08-08 | Anant Sharma | Eye Massage Device |
| US10842670B2 (en) | 2012-08-22 | 2020-11-24 | Johnson & Johnson Vision Care, Inc. | Apparatuses and methods for diagnosing and/or treating lipid transport deficiency in ocular tear films, and related components and devices |
| US9339177B2 (en) | 2012-12-21 | 2016-05-17 | Tearscience, Inc. | Full-eye illumination ocular surface imaging of an ocular tear film for determining tear film thickness and/or providing ocular topography |
| US9763827B2 (en) | 2013-04-30 | 2017-09-19 | Tear Film Innovations, Inc. | Systems and methods for the treatment of eye conditions |
| WO2014179795A2 (en) * | 2013-05-03 | 2014-11-06 | Tearscience, Inc. | Eyelid illumination systems and methods for imaging meibomian glands for meibomian gland analysis |
| US9795290B2 (en) | 2013-11-15 | 2017-10-24 | Tearscience, Inc. | Ocular tear film peak detection and stabilization detection systems and methods for determining tear film layer characteristics |
| WO2016070134A1 (en) * | 2014-10-30 | 2016-05-06 | Tear Film Innovations, Inc. | Systems and methods for the treatment of eye conditions |
| CN105520805B (zh) * | 2016-02-04 | 2017-11-07 | 张晨明 | 赶压式睑板腺功能障碍治疗装置 |
| US10974063B2 (en) | 2016-06-30 | 2021-04-13 | Alcon Inc. | Light therapy for eyelash growth |
| TWI772314B (zh) * | 2016-07-12 | 2022-08-01 | 德商得瑪法公司 | 用於瘙癢症的高熱治療之裝置 |
| LT3308752T (lt) * | 2016-10-11 | 2020-07-27 | Dermapharm Ag | Niežėjimo gydymo hiperterminiu būdų prietaisas |
| EP3618783B1 (en) | 2017-05-05 | 2023-07-05 | Craig Litherland | Devices for treating eyelids |
| WO2019033339A1 (en) * | 2017-08-17 | 2019-02-21 | Xinova, LLC | DISPOSABLE CONTACT LENS FOR OPTICAL PROCESSING SYSTEMS |
| US20200179168A1 (en) * | 2018-12-06 | 2020-06-11 | Alcon Inc. | Systems and methods for the treatment of eye conditions |
| WO2020130176A1 (ko) * | 2018-12-19 | 2020-06-25 | 부산대학교 산학협력단 | 안구 건조증 치료용 장치 |
| CN109771127A (zh) * | 2019-02-27 | 2019-05-21 | 浙江花园润嘉医疗器械有限公司 | 干眼症治疗仪及其控制方法 |
| CN111658305A (zh) * | 2020-05-21 | 2020-09-15 | 李秀岩 | 一种带眼压传感器的温控眼压感应眼加热电热膜 |
| CN115957067A (zh) * | 2021-10-09 | 2023-04-14 | 上海臻复医疗科技有限公司 | 眼部冷敷装置 |
| CN114081716B (zh) * | 2022-01-22 | 2022-04-12 | 南方医科大学深圳医院 | 用于向睑板腺递送药物的装置 |
| CN117562733A (zh) * | 2022-08-08 | 2024-02-20 | 上海臻复医疗科技有限公司 | 眼杯以及眼部治疗装置 |
| KR20250103563A (ko) * | 2023-12-26 | 2025-07-07 | 주식회사 옵트로쓰 | 온열 시스템을 구비하는 스마트 콘택트렌즈 |
| WO2025199573A1 (en) * | 2024-03-27 | 2025-10-02 | Nthalmic Holding Pty Ltd | Smart wearable device to treat meibomian gland deficiencies |
| CN118304085A (zh) * | 2024-04-11 | 2024-07-09 | 沪湾生物科技(上海)有限公司 | 睑板腺治疗装置 |
| CN119235542B (zh) * | 2024-10-31 | 2025-07-29 | 华创视康(深圳)医疗科技有限公司 | 眼睑热敷装置 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3140390A (en) | 1963-06-12 | 1964-07-07 | Smith Percy | Therapeutic appliance |
| US5958912A (en) | 1992-04-21 | 1999-09-28 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens of TGF-β |
| US6107289A (en) | 1992-04-21 | 2000-08-22 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
| JPH06269473A (ja) * | 1993-03-19 | 1994-09-27 | Santen Pharmaceut Co Ltd | 携帯式眼部加温器 |
| WO1997020578A1 (en) | 1995-12-04 | 1997-06-12 | University Of Miami | Non-preserved topical corticosteroid for treatment of dry eye, filamentary keratitis, and delayed tear clearance |
| JPH11221247A (ja) * | 1997-08-25 | 1999-08-17 | Seputo:Kk | 温熱付眼鏡 |
| DK1676579T3 (da) | 1998-05-08 | 2009-03-16 | Univ Miami | Anvendelse af sub-antimikrobielle tetracykliner til behandling af okulær rosacea |
| TW539564B (en) * | 1999-05-25 | 2003-07-01 | Iomed Inc | Methods and apparatus for ocular iontophoresis |
| JP3613634B2 (ja) * | 2001-11-06 | 2005-01-26 | 得一郎 長谷川 | 視力矯正装置 |
| GB2384430B (en) * | 2002-01-24 | 2003-12-03 | John Robert Fuller | Therapeutic eye and eyelid cover |
| GB0225795D0 (en) * | 2002-11-05 | 2002-12-11 | Guillon Michael | Wipes |
| US7513893B2 (en) * | 2004-03-12 | 2009-04-07 | Abraham Ebbie Soroudi | Device and method for treatment of eyelid diseases |
| DE602005026978D1 (de) * | 2004-11-23 | 2011-04-28 | Timothy L Lee | Medizinische vorrichtung zur temperaturregelung und behandlung des auges sowie des umgebenden gewebes |
| JP2006198249A (ja) * | 2005-01-21 | 2006-08-03 | Rohto Pharmaceut Co Ltd | ドライアイ治療用具 |
| WO2008024100A2 (en) * | 2006-08-21 | 2008-02-28 | Tearscience, Inc. | Method and apparatus for treating gland dysfunction |
| US8083787B2 (en) | 2005-07-18 | 2011-12-27 | Tearscience, Inc. | Method and apparatus for treating meibomian gland dysfunction |
-
2008
- 2008-01-17 BR BRPI0806635-3A patent/BRPI0806635A2/pt not_active Application Discontinuation
- 2008-01-17 EP EP18192086.9A patent/EP3434313A1/en not_active Withdrawn
- 2008-01-17 JP JP2009546506A patent/JP5406728B2/ja not_active Expired - Fee Related
- 2008-01-17 CN CN201310017761.3A patent/CN103181837B/zh not_active Expired - Fee Related
- 2008-01-17 ES ES08727830.5T patent/ES2692434T3/es active Active
- 2008-01-17 CN CN2008800087417A patent/CN101663064B/zh active Active
- 2008-01-17 CN CN201310017764.7A patent/CN103083131B/zh active Active
- 2008-01-17 WO PCT/US2008/051309 patent/WO2008089327A1/en not_active Ceased
- 2008-01-17 SG SG2012003638A patent/SG177990A1/en unknown
- 2008-01-17 EP EP08727830.5A patent/EP2121109B1/en active Active
- 2008-01-17 SG SG2012003646A patent/SG177991A1/en unknown
-
2009
- 2009-07-16 IL IL199920A patent/IL199920A0/en unknown
-
2013
- 2013-10-31 JP JP2013226709A patent/JP2014087649A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014087649A (ja) | 2014-05-15 |
| JP2010516343A (ja) | 2010-05-20 |
| JP5406728B2 (ja) | 2014-02-05 |
| CN103181837B (zh) | 2015-04-22 |
| WO2008089327A1 (en) | 2008-07-24 |
| SG177990A1 (en) | 2012-02-28 |
| EP2121109A4 (en) | 2013-01-23 |
| CN101663064B (zh) | 2013-03-06 |
| CN103181837A (zh) | 2013-07-03 |
| SG177991A1 (en) | 2012-02-28 |
| EP3434313A1 (en) | 2019-01-30 |
| EP2121109A1 (en) | 2009-11-25 |
| CN103083131B (zh) | 2015-07-22 |
| CN101663064A (zh) | 2010-03-03 |
| BRPI0806635A2 (pt) | 2011-09-06 |
| EP2121109B1 (en) | 2018-09-05 |
| CN103083131A (zh) | 2013-05-08 |
| IL199920A0 (en) | 2010-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103181837B (zh) | 用于治疗睑板腺功能障碍的热处理的系统和装置 | |
| US20210205131A1 (en) | Methods and apparatuses for treatment of meibomian gland dysfunction | |
| US7981146B2 (en) | Inner eyelid treatment for treating meibomian gland dysfunction | |
| US7976573B2 (en) | Inner eyelid heat and pressure treatment for treating meibomian gland dysfunction | |
| US7981147B2 (en) | Outer eyelid heat and pressure treatment for treating meibomian gland dysfunction | |
| US8617229B2 (en) | System for outer eyelid heat and pressure treatment for treating meibomian gland dysfunction | |
| US8632578B2 (en) | System for providing heat treatment and heat loss reduction for treating meibomian gland dysfunction | |
| US9314369B2 (en) | System for inner eyelid treatment of meibomian gland dysfunction | |
| US8523928B2 (en) | System for inner eyelid heat and pressure treatment for treating meibomian gland dysfunction | |
| US8007524B2 (en) | Heat treatment and heat loss reduction for treating meibomian gland dysfunction | |
| ES3018285T3 (en) | Eye thermal compress | |
| US20140066821A1 (en) | Methods, apparatuses, and systems for reducing intraocular pressure as a means of preventing or treating open-angle glaucoma | |
| JP2004350803A (ja) | アイマスク及び視力矯正治具 | |
| JP2010504769A (ja) | マイボーム腺閉塞の溶解 | |
| WO2008039221A1 (en) | Providing gas and vapor to a patient |